01 1ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy IN
02 1HARMAN FINOCHEM LIMITED Mumbai IN
03 1MIDAS PHARMA GMBH Ingelheim am Rhein DE
04 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
01 3Clofazimine
02 1Clofazimine, Triclinic form
01 1China
02 1Germany
03 2India
01 4Valid
Certificate Number : R0-CEP 2023-008 - Rev 00
Status : Valid
Issue Date : 2023-08-08
Type : Chemical
Substance Number : 2054
Certificate Number : CEP 2024-201 - Rev 00
Status : Valid
Issue Date : 2024-12-06
Type : Chemical
Substance Number : 2054
Certificate Number : CEP 2019-257 - Rev 02
Status : Valid
Issue Date : 2025-06-17
Type : Chemical
Substance Number : 2054
Certificate Number : R1-CEP 2016-291 - Rev 00
Status : Valid
Issue Date : 2023-01-10
Type : Chemical
Substance Number : 2054
68
PharmaCompass offers a list of Clofazimine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clofazimine manufacturer or Clofazimine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clofazimine manufacturer or Clofazimine supplier.
PharmaCompass also assists you with knowing the Clofazimine API Price utilized in the formulation of products. Clofazimine API Price is not always fixed or binding as the Clofazimine Price is obtained through a variety of data sources. The Clofazimine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine, including repackagers and relabelers. The FDA regulates N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine supplier is an individual or a company that provides N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine active pharmaceutical ingredient (API) or N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine finished formulations upon request. The N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine suppliers may include N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine API manufacturers, exporters, distributors and traders.
click here to find a list of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP of the European Pharmacopoeia monograph is often referred to as a N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine Certificate of Suitability (COS). The purpose of a N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine to their clients by showing that a N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP has been issued for it. The manufacturer submits a N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP (COS) as part of the market authorization procedure, and it takes on the role of a N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP holder for the record. Additionally, the data presented in the N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine DMF.
A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine suppliers with CEP (COS) on PharmaCompass.
We have 4 companies offering N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
Get in contact with the supplier of your choice:
